baber/WOPTO huggingface dataset:
Patent AU-2015205885-A1 (AU)
Title: Novel 7-deazapurine nucleosides for therapeutic uses
Inventor: BOURDERIOUX AURELIE
IPC: C07H19/23
Filed: 2015-07-22
Abstract: Abstract Title NOVEL 7-DEAZAPURINE NUCLEOSIDES FOR THERAPEUTIC The invention provides compounds of formula I, wherein R1, R 2 and R 3 have values defined in the specification and a pharmaceutically acceptable salt thereof; or an optical isomer thereof; or a mixture of optical isomers, as well as compositions comprising such compounds and therapeutic methods that utilize such compounds and/or compositions.
Patent AU-2015230938-A1 (AU)
Title: Non-human animals that make single domain binding proteins
Inventor: MACDONALD LYNN
IPC: C12N15/85
Filed: 2015-03-20
Abstract: Genetically modified non-human animals and methods and compositions for making and using them are provided, wherein the genetic modification comprises (a) a deletion in an immunoglobulin constant region C
Patent AU-2015241422-A1 (AU)
Title: Methods and compositions for immunomodulation
Inventor: MATA-FINK JORDI
IPC: C12N5/07
Filed: 2015-03-13
Abstract: Provided are cells containing exogenous antigen and uses thereof.
Patent AU-2015246147-A1 (AU)
Title: Intra-prediction method, and encoder and decoder using same
Inventor: PARK JOONYOUNG
IPC: H04N19/105
Filed: 2015-10-23
Abstract: The present invention relates to an intra-prediction method and to an encoder and decoder 5 using same. The intra-prediction method according to one embodiment of the present invention comprises the steps of: deriving a prediction mode of a current block; and generating a prediction block with respect to the current block on the basis of the prediction mode of the current block. When the prediction mode of the current block is an intra-angular prediction mode, values of boundary samples from among left boundary samples and upper boundary samples of the prediction block, which are not 0 positioned in a prediction direction of the intra-angular prediction mode, are derived on the basis of reference samples positioned in the prediction direction of the intra-angular prediction mode, and on the basis of adjacent reference samples. f/'14 x=-1..2*nS-1 . . . y=0..nS-1 y=-1..2*nS-1 620" x=..nS-1
Patent AU-2015252110-A1 (AU)
Title: Method of purifying polypeptides
Inventor: CHARLTON ADAM
IPC: C07K1/22
Filed: 2015-11-05
Abstract: The present invention relates to improved processes for purifying polypeptides of interest by increasing the amount of polypeptide of interest bound to an ion-exchange matrix relative to the amount of one or more impurities bound to the ion-exchange matrix. 5 This effect is achieved by adding a chemical compound in the process which by also binding to the ion-exchange matrix due to a change that is opposite to the change of the ion-exchange matrix, reduces the binding of impurities more than the binding of the polypeptide of interest.
Patent AU-2015255191-A1 (AU)
Title: A method of gaming, a gaming system and a game controller
Inventor: PLOWMAN GREGORY LEIGH
IPC: G07F17/34
Filed: 2015-11-10
Abstract: Abstract A method of gaming in a gaming machine having a display and a game controller, the display having a plurality of display 5 positions. The method comprises conducting, via the game controller, a play round comprising selecting, via the game controller, a first set of symbols from a plurality of available symbols that includes at least one special symbol, displaying the selected first set of symbols at a respective display 10 positions, and determining, via the game controller, a game outcome based on the first set of symbols and any special symbols that are selected and displayed. The method comprises conducting, via the game controller, one or more further play rounds until an end condition is met. Each further play round 15 comprises determining, via the game controller, if two or more special symbols are displayed at respective first display positions from the previous round, and if so retaining the two or more special symbols for the further round, if two or more special symbols are displayed at the respective first display 20 positions, selecting, via the game controller, new and different display positions at random for each of the two or more retained special symbols based upon a first set of predetermined displacement rules, selecting, via the game controller, a further set of symbols from a plurality of 25 available display symbols, displaying the selected further set of symbols at respective display positions, and determining, via the game controller, a further game outcome based on the further set of symbols and the two or more retained special symbols, determining, via the gaming controller, if any two or 30 more of the retained special symbols have been randomly moved to a same display position, combining, via the gaming controller, the two or more special symbols when the same display position is randomly selected for the at least two special symbols, and moving, via the gaming controller, the combined symbol in 35 subsequent further rounds based on a second set of predetermined displacement rules. 7102636 1 (GHMatters) P62710.AU.3 NICK 10/11/15 1050 MEMORY NORMAL 1041 SYMBOL SELECTOR 4 SYMBOL SPECIAL SYMBOL Display CONTROLLER 11043 Display 12 PCA NEWPOSITION DT DISPLACEMENT 1046 L* GAME OUTCOME INSTRUCTIONS Figure 6 7102636 1 (GHMatters) P62710.AU.4 NICK 10/11/15
Patent AU-2015269494-A1 (AU)
Title: Winding machine
Inventor: KUSE KEITA
IPC: B29C63/30
Filed: 2015-06-04
Abstract: A pipe-making machine (1) is provided with a main body (20), a first arm (40), and a second arm (50). The main body (20) moves forward in a pipe making direction in conjunction with addition of a band-shaped member (100) while rotating at a front-end part in the pipe making direction of a preceding pipe-shaped body (4). The first arm (40) and the second arm (50) are each supported by the main body (20) in positions separated in the circumferential direction of the preceding pipe-shaped body (4), and each extend to the rear in the pipe making direction between an existing pipe (2) and the preceding pipe-shaped body (4). The first arm (40) has a first restricting part (43) in contact via the band-shaped member (100) with a front side in the pipe making direction of a reinforcing member (120) provided to the band-shaped member (100) constituting the preceding pipe-shaped body (4). The second arm (50) has a second restricting part (52) in contact via the band-shaped member (100) with the reverse side of the reinforcing member (120) from the side thereof contacted by the first restricting part (43), the reinforcing member (120) being provided to the band-shaped member (100) constituting the preceding pipe-shaped body (4).
Patent AU-2015281753-A1 (AU)
Title: Antimicrobial-antibiofilm compositions and methods of use thereof for personal care products
Inventor: GAWANDE PURUSHOTTAM V
IPC: A01P1/00
Filed: 2015-06-26
Abstract: Compositions comprising one or more chelating agents and optionally zinc ion salts are used to inhibit the growth or biofilm formation in bacteria associated with personal care products such as ophthalmic, pedicure, manicure or podiatric solutions. The compositions of the present application can also comprise gelling agents, antimicrobials, antibiotic or a pH adjuster. The compositions may be in the form of a solution, a gel, a cream, a jelly, a powder, a paste, a lotion, soap and a cleaner.
Patent AU-2015286639-A1 (AU)
Title: Tooth and adaptor for dredging machine
Inventor: TRIGINER BOIXEDA JORGE
IPC: E02F9/28
Filed: 2015-07-10
Abstract: The tooth and adaptor for dredging machines object of the present invention relates to a tooth which, attached to an adaptor, creates an assembly the purpose of which is to deepen and clean the beds of ports, rivers, channels, etc., removing therefrom sludge, stones, sand, etc., the adaptors being attached to the blades thus forming the cutter head of the dredging machine. The constructive features of the coupling between the tooth and the adaptor allow a great stability between both elements, among other advantages.
Patent AU-2015287926-A1 (AU)
Title: Pump apparatus and methods for expression of human breast milk
Inventor: ALVAREZ JEFFERY B
IPC: A61M1/06
Filed: 2015-07-07
Abstract: Improved devices, systems and methods for the expression of milk from a breast are disclosed herein. A device for expression of milk may comprise a peristaltic pump configured to move a fluid to or from a breast interface, so as to apply pressure at the breast interface and thereby express milk from the breast. The peristaltic pump can be removably coupled to a tube carrying the fluid, so as to maintain a separation between the peristaltic pump and the fluidly coupled components of the device. A device for expressing breast milk may further comprise an adjustable breast interface configured to engage and fluidly seal against the human breast. The adjustable breast interface may be manually or automatically adjustable to fluidly seal against a plurality of sizes or shapes of human breasts.
Patent AU-2015303098-A1 (AU)
Title: Securing device
Inventor: CHAPMAN ROBERT ERNEST
IPC: F16B13/08
Filed: 2015-08-06
Abstract: A securing device (10) is mountable on an article, and comprises a guide formation (14). A fastening arrangement (18) is movable relative to the guide formation to fasten the article to the securing device. An urging arrangement (26) is operable to urge the fastening arrangement relative to the guide formation between fastening and non-fastening positions. The guide formation is arranged to guide the fastening arrangement to the fastening position. An indicator (38) is movable by the urging arrangement from a non-indicating condition to an indicating condition when the fastening arrangement is moved to the fastening position.
Patent AU-2015308625-A1 (AU)
Title: Antibody therapeutics that bind OprF and Oprl
Inventor: ZHOU HEYUE
IPC: A61K39/104
Filed: 2015-08-28
Abstract: There is disclosed compositions and methods relating to or derived from anti-OprF and anti-Oprl antibodies. More specifically, there is disclosed fully human antibodies that bind OprF and Oprl, OprF and Oprl-antibody binding fragments and derivatives of such antibodies, and OprF and Oprl-binding polypeptides comprising such fragments. Further still, there is disclosed nucleic acids encoding such antibodies, antibody fragments and derivatives and polypeptides, cells comprising such polynucleotides, methods of making such antibodies, antibody fragments and derivatives and polypeptides, and methods of using such antibodies, antibody fragments and derivatives and polypeptides, including methods of treating or diagnosing subjects having
Patent AU-2015308755-A1 (AU)
Title: Bone fixation devices and methods
Inventor: WEINER LON S
IPC: A61B17/80
Filed: 2015-08-28
Abstract: The present disclosure provides devices, systems and methods of bone fixation. The disclosed devices, systems and methods facilitate secure fixation of first and second bone segments, such as to promote fusion thereof. The devices may include at least one bone engagement projection extending from an engagement surface of a plate portion for implantation into the first bone segment. A portion of the plate portion spaced from the at least one bone engagement projection may include at least one bone fixation aperture. The least one bone fixation aperture may allow for a one bone engagement projection to be inserted therethrough and into the second bone segment to affix the plate portion to the second bone segment. In some embodiments, the at least one bone fixation aperture may be a compression slot.
Patent AU-2015311726-A1 (AU)
Title: Slick-water fracturing using time release metal-complexing agent
Inventor: CONWAY ANDREW BRYCE
IPC: C09K8/68
Filed: 2015-09-04
Abstract: In a slick-water fracturing operation, a composition is used to prevent the interaction between a polymer in a water-based fracturing fluid and naturally-occurring metal ions. The composition includes a metal-complexing agent, such as a chelating agent. The chelating agent can also be biodegradable and is citric acid in embodiments. The metal-complexing agent can be coated with one or two coatings to create a time-released form. The time -released form prevents loss of the agent prior to delivery at the shale.
Patent AU-2015343719-A1 (AU)
Title: Adsorbing contaminants from a gas stream
Inventor: CALAFELL DAG O
IPC: B01J20/30
Filed: 2015-09-14
Abstract: A method and systems for adsorbing contaminants from a gas stream (206) are provided herein. The method includes flowing the gas stream (206) into a treating vessel (210) and through a moving bed of adsorbents (202). The method includes flowing the adsorbents (220) out of the treating vessel and into a fluidized bed (204) of a regenerator (222). The method includes desorbing the contaminants from the adsorbents in the fluidized bed of the regenerator to form regenerated adsorbents. The method further includes cooling (232) the adsorbents and returning (234) the cooled, regenerated adsorbents to the treating vessel (210).
Patent AU-2015349878-A1 (AU)
Title: Antibodies against CD73 and uses thereof
Inventor: LONBERG NILS
IPC: C07K16/40
Filed: 2015-11-19
Abstract: The present disclosure provides isolated monoclonal antibodies, particularly human antibodies, that bind to human Cluster of Differentiation 73 (CD73) with high affinity, and inhibit the activity of CD73, and optionally mediate antibody dependent CD73 internalization. Nucleic acid molecules encoding the antibodies of the disclosure, expression vectors, host cells and methods for expressing the antibodies of the disclosure are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the disclosure are also provided. The disclosure also provides methods for inhibiting the growth of a tumor cell expressing CD73 using the antibodies of the disclosure, including methods for treating various cancers.
Patent AU-2015376657-A1 (AU)
Title: Image change detection
Inventor: KLOER BRIAN R
IPC: G06K9/00
Filed: 2015-06-12
Abstract: Abstract A system, method, and computer program product compare images of a physical activity or object. Pixel data from first and second registered color images defined in an N dimensional color model are concatenated to form an image in a 2N-dimensional color model. Principal component analysis is performed on the composite image and those components representing a change rather than a correlation are identified. In the composite image, coordinates for each pixel are determined along the principal components representing change, and a normalized pixel change value is computed. Pixels in the composite image may be segmented according to their respective normalized pixel change values, where segments do not cross pre-defined geospatial parcel boundaries. Parcel change probabilities are calculated as a function of segment change probabilities, themselves functions of the normalized pixel change values. Finally, parcels are ranked by their change probabilities and highlighted in a graphical user interface. Page 29 2762057v1
Patent AU-2016202283-A1 (AU)
Title: System and method for inhibiting scale formation in oil wells
Inventor: KOSKAN LARRY P
IPC: E21B43/16
Filed: 2016-04-12
Abstract: An illustrative method of reducing an amount of treatment water inj ected into a subterranean well may include providing an environmentally friendly polymer, such 5 as a biodegradable polymer (e.g., an aspartic acid based polymer), to the subterranean well. In some cases, the aspartic acid based polymer may include one or more of a copolymer of the aspartic acid based polymer, a terpolymer of the aspartic acid based polymer, an aspartic acid based polymer derivative, an aspartic acid based polymer having an end cap, and a soluble salt of the aspartic acid based polymer. In some 10 cases, the treatment water use may be reduced within the range of about five percent to about ninety five percent.
Patent AU-2016211612-A1 (AU)
Title: Map-like summary visualization of street-level distance data and panorama data
Inventor: PYLVAENAEINEN TIMO
IPC: G08B13/196
Filed: 2016-01-26
Abstract: Architecture that summarizes a large amount (e.g., thousands of miles) of street-level image/video data of different perspectives and types (e.g., continuous scan-type data and panorama-type data) into a single view that resembles aerial imagery. Polygons surfaces are generated from the scan patterns and the image data is projected onto the surfaces, and then rendered into the desired orthographic projection. The street-level data is processed using a distributed computing approach across cluster nodes. The collection is processed into image tiles on the separate cluster nodes representing an orthographic map projection that can be viewed at various levels of detail. Map features such as lower-level roads, that are at lower elevations than higher-level roads, and are hidden by higher-level overpassing roads, can be navigated in the map. With the summarized data, the maps can be navigated and zoomed efficiently.
Patent AU-2016213755-A1 (AU)
Title: System and method for performing motion capture and image reconstruction with transparent makeup
Inventor: PERLMAN STEPHEN G
IPC: H04N5/225
Filed: 2016-08-10
Abstract: A system and method are described for performing motion capture on a subject using transparent makeup, paint, dye or ink that is visible to certain cameras, but invisible to other cameras. For example, a system according to one embodiment of the invention comprises the application of makeup, paint, dye or ink on a subject in a random pattern that contains a phosphor that is transparent in the visible light spectrum, but is emissive in a non-visible spectrum such as the infrared (IR) or ultraviolet (UV) spectrum; using visible light such as ambient light or daylight to illuminate the subject; using a first plurality of cameras sensitive in the visible light spectrum to capture the normal coloration of the subject; and using a second plurality of cameras sensitive in a non-visible spectrum to capture the random pattern.
Patent AU-2016216587-A1 (AU)
Title: Freight restraint
Inventor: MCNAULTY DANIEL DAVID
IPC: B60P7/15
Filed: 2016-08-16
Abstract: A restraint gate for an open sided vehicle or container having a roof and a floor, the gate including a rigid frame supported by a post; the post having an upper end adapted to be hung from the roof at an open side of the vehicle or container; a lower end of the gate adapted to engage the floor or a coaming associated with the floor to locate the gate in position between the roof and the floor or coaming so that the gate acts as a restraint against lateral displacement of a load on the vehicle or container; and a biasing means connected between the post and the frame, the biasing means adapted to bias the frame in a upwardly direction relative to the post to facilitate disengagement of the lower end of the gate from the floor or coaming. <filename> Vt 'iNt F11r
Patent AU-2016216637-A1 (AU)
Title: Composition and method for treating or preventing skeletal muscle fibrosis
Inventor: PINES MARK
IPC: A61K31/519
Filed: 2016-08-18
Abstract: COMPOSITION AND METHOD FOR TREATING OR PREVENTING SKELETAL MUSCLE FIBROSIS Abstract A compound in combination with a pharmaceutically acceptable carrier, the compound having a formula: wherein: R1 is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl, and lower alkoxy; R2 is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy; and R 3 is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl; and n is either 1 or 2; and pharmaceutically acceptable salts thereof, for use in treatment of or prevention of skeletal muscle fibrosis and/or for inducing skeletal muscle regeneration.
Patent AU-2016222329-A1 (AU)
Title: Positively charged water-soluble pro-drugs of ibuprofen
Inventor: XU LINA
IPC: C07C211/63
Filed: 2016-08-30
Abstract: POSITWELY CHARGE WATER R-SOLUBLE PRO-DRUGS OF IBUPROFEN The novel positively charged pro-drugs of ibuprofen in the general formula (1) "Structure 1" were designed and synthesized. The compounds of the general formula (I) "Structure 1" indicated above can be prepared from functional derivatives of ibuprofen, (for example acid halides or mixed anhydrides), by reaction with suitable alcohols, thiols, or amines. The positively charged amino groups of these pro-drugs not only largely increases the solubility of the drugs, but also bonds to the negative charge on the phosphate head group of membranes and pushes the pro-drug into the cytosol. The experiment results suggest that the pro-drug, diethylaminoethyl 2-(p-isobutylphenyl) propionate.AcOH, diffuses through human skin -250 times faster than ibuprofen itself and -125 times faster than ethyl 2-(p isobutylphenyl) propionate. In plasma, more than 90% of these pro-drugs can change back to the drug in a few minutes. The prodrugs can be used medicinally in treating any ibuprofen treatable conditions in humans or animals and be administered not only orally, but also transdermally for any kind of medical treatments and avoid most of the side effects of ibuprofen, most notably ( GI disturbances such as dyspepsia, gastroduodenal bleeding, gastric ulcerations, and gastritis. Controlled transdermal administration systems of the prodrug enables the ibuprofen to reach constantly optimal therapeutic blood levels to increase effectiveness and reduce the side effects of ibuprofen.
Patent AU-2016238909-A1 (AU)
Title: Pharmaceutical cream compositions comprising oxymetazoline
Inventor: SHANLER STUART D
IPC: A61K31/4174
Filed: 2016-10-06
Abstract: PHARMACEUTICAL CREAM COMPOSITIONS COMPRISING OXYMETAZOLINE Abstract: Mozist Dry Irritate App Over Absorp_______________ Ease oTrial_20 ---------- --------- -I ~ra2 Elegant W Trial11 oily Trial 2 a Trial 36 ---- ------------------------------ - Color Ap - - ------------------ - -FI , App --------------------------- ---------------------- t-~---- FIG 1 Embodiments relating to cream formulations as well as oxymetazoline creams and methods for treating rosacea and symptoms associated with rosacea, including, for example, papules, pustules, phymas (skin thickening), telangiectasias or erythema associated with rosacea, other skin erythemas, telangiectasias, purpura or the like, and other manifestations associated therewith; other inflammatory conditions of the skin including, but not limited to, keratosis pilaris, lupus miliaris dissemniatus faciei, eczema, dermatitis, such as contact dermatitis, atopic dermatitis, seborrheic dermatitis, nummular dermatitis, generalized exfoliative dermatitis, statis dermatitis, neurodermatitis, lichen simplex chronicus, xerosis and xerotic dermatitis, dyshidrosis and dyshidrotic dermatitis, asteototic dermatitis or other conditions characterized by sensitive skin or a disturbance of the epidermal barrier; disorders characterized by rough, dry, cracked or fissured skin, disorders characterized by hyperkeratotic skin such as keratodermas and ichthyosisis and ichthyosiform dermatoses; disorders of hair follicles and sebaceous glands, such as acne, perioral dermatitis, and pseudofolliculitis barbae; disorders of sweat glands, such as miliaria, including, but not limited to, miliaria crystallina, miliaria rubra, miliaria profunda, miliaria pustulosa; sunburn, chronic actinic damage, poikiloderma, radiation dermatitis, actinic purpura ("solar purpura"); other inflammatory dermatoses, reactions and conditions of the skin, including, but not limited to, psoriasis, drug eruptions, erythema multiforme, erythema nodosum, and granuloma annulare; diseases and conditions characterized by bleeding or bruising such as petechiae, ecchymosis, purpura and the like including any accumulation of blood in the skin due to vascular extravasation, irrespective of size or cause, bleeding or bruising due to any skin injury which may include any trauma including surgical or procedural trauma; infection, inflammatory dermatoses or inflammation due to any cause using such creams are described herein.